LoginSignup
Amgen logo

Amgen

Stock
Stock
ISIN: US0311621009
Ticker: AMGN
US0311621009
AMGN

Price

Price

Historical dividends and forecast

All dividend data

Amgen has so far distributed $6.75 in 2024. The next dividend will be paid on 09.12.2024

$4.805

CHART BY

Frequently asked questions

What is Amgen's market capitalization?

The market capitalization of Amgen is $154.74B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Amgen's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Amgen is 36.83. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Amgen?

Amgen's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $7.815. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Amgen's stock?

Currently, 29 analysts cover Amgen's stock, with a consensus target price of $318.45. Analyst ratings provide insights into the stock's expected performance.

What is Amgen's revenue over the trailing twelve months?

Over the trailing twelve months, Amgen reported a revenue of $32.53B.

Is Amgen paying dividends?

Yes, Amgen is paying dividends. The next payment is scheduled for 09.12.2024, with an expected amount of .

What is the EBITDA for Amgen?

Amgen's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $11.81B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Amgen?

Amgen has a free cash flow of $1.52B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Amgen's stock?

The 5-year beta for Amgen is 0.57. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Amgen have, and what sector and industry does it belong to?

Amgen employs approximately 26,700 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Amgen's shares?

The free float of Amgen is 536.20M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $154.74B

5Y beta

 0.57

EPS (TTM)

 $7.815

Free Float

 536.20M

P/E ratio (TTM)

 36.83

Revenue (TTM)

 $32.53B

EBITDA (TTM)

 $11.81B

Free Cashflow (TTM)

 $1.52B

Pricing

1D span
$284.58$291.99
52W span
$260.68$346.85

Analyst Ratings

The price target is $318.45 and the stock is covered by 29 analysts.

Buy

14

Hold

12

Sell

3

Information

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine), KYPROLIS (carfilzomib), Maridebart cafraglutide, (infliximab-axxq), Evenity, LumaKras, Nplate and XGeva, others.

26,700

Biotechnology & Drugs

Health Care

Identifier

ISIN

US0311621009

Primary Ticker

AMGN

Knockouts

Join the conversation
Sign upLogin